RFG Advisory LLC Increases Holdings in Thermo Fisher Scientific Inc. $TMO

RFG Advisory LLC increased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 35.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,231 shares of the medical research company’s stock after acquiring an additional 850 shares during the period. RFG Advisory LLC’s holdings in Thermo Fisher Scientific were worth $1,620,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the company. Ramsay Stattman Vela & Price Inc. increased its holdings in Thermo Fisher Scientific by 1.2% during the 2nd quarter. Ramsay Stattman Vela & Price Inc. now owns 16,215 shares of the medical research company’s stock valued at $8,130,000 after acquiring an additional 199 shares in the last quarter. Veritas Asset Management LLP lifted its stake in Thermo Fisher Scientific by 4.4% in the 2nd quarter. Veritas Asset Management LLP now owns 882,873 shares of the medical research company’s stock valued at $442,637,000 after buying an additional 36,878 shares in the last quarter. West Family Investments Inc. grew its holdings in Thermo Fisher Scientific by 132.6% during the 2nd quarter. West Family Investments Inc. now owns 1,428 shares of the medical research company’s stock valued at $716,000 after buying an additional 814 shares during the last quarter. Empirical Finance LLC increased its position in Thermo Fisher Scientific by 3.3% during the second quarter. Empirical Finance LLC now owns 13,473 shares of the medical research company’s stock worth $6,755,000 after buying an additional 431 shares in the last quarter. Finally, Nykredit A S acquired a new position in shares of Thermo Fisher Scientific in the second quarter worth $53,929,000. 89.23% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

TMO has been the subject of a number of recent research reports. Piper Sandler assumed coverage on Thermo Fisher Scientific in a research report on Wednesday. They set an “overweight” rating for the company. HSBC upgraded Thermo Fisher Scientific from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 1st. Deutsche Bank Aktiengesellschaft cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday. Morgan Stanley upped their price objective on shares of Thermo Fisher Scientific from $620.00 to $650.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. Finally, Royal Bank Of Canada raised their target price on shares of Thermo Fisher Scientific from $490.00 to $580.00 and gave the stock a “sector perform” rating in a research report on Friday, July 24th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Thermo Fisher Scientific currently has an average rating of “Moderate Buy” and a consensus price target of $624.64.

Thermo Fisher Scientific Stock Performance

Shares of TMO stock opened at $610.97 on Friday. The company’s fifty day simple moving average is $580.40 and its 200-day simple moving average is $518.55. The company has a current ratio of 1.55, a quick ratio of 1.18 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 52 week low of $435.27 and a 52 week high of $647.00. The company has a market cap of $225.90 billion, a PE ratio of 32.87, a P/E/G ratio of 2.52 and a beta of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Thursday, July 23rd. The medical research company reported $6.03 EPS for the quarter, beating the consensus estimate of $5.71 by $0.32. Thermo Fisher Scientific had a return on equity of 17.09% and a net margin of 15.04%.The company had revenue of $11.99 billion for the quarter, compared to analyst estimates of $11.71 billion. During the same period last year, the company posted $4.28 earnings per share. The firm’s revenue was up 10.5% compared to the same quarter last year. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. As a group, equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 25.13 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be given a $0.47 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.88 annualized dividend and a yield of 0.3%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.11%.

Insider Activity

In other Thermo Fisher Scientific news, EVP Michael D. Shafer sold 25,500 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $600.00, for a total value of $15,300,000.00. Following the completion of the transaction, the executive vice president directly owned 20,994 shares of the company’s stock, valued at $12,596,400. This represents a 54.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Joseph R. Holmes sold 420 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $584.81, for a total value of $245,620.20. Following the sale, the chief accounting officer directly owned 2,966 shares in the company, valued at approximately $1,734,546.46. The trade was a 12.40% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 73,768 shares of company stock worth $44,122,820. Company insiders own 0.33% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc is a global supplier of scientific equipment, laboratory services and analytical technologies. The company serves pharmaceutical and biotechnology companies, clinical laboratories, academic and government institutions, industrial businesses and other research organizations.

Its products and services include laboratory instruments, analytical systems, reagents, consumables, software and related services. Thermo Fisher also provides laboratory supplies and equipment, bioproduction solutions, genetic analysis technologies, clinical diagnostics, specialty diagnostic products and contract research and manufacturing services through its laboratory services businesses.

The company was formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International.